about
Trial watch: Dendritic cell-based anticancer therapyCollaboration of Toll-like and RIG-I-like receptors in human dendritic cells: tRIGgering antiviral innate immune responsesNeonatal Vaccination: Challenges and Intervention StrategiesT-Regulatory Cells and Vaccination "Pay Attention and Do Not Neglect Them": Lessons from HIV and Cancer Vaccine TrialsCCL21 Cancer Immunotherapy.Immunomodulatory Functions of BTLA and HVEM Govern Induction of Extrathymic Regulatory T Cells and Tolerance by Dendritic Cells.Osteopathic manipulative therapy induces early plasma cytokine release and mobilization of a population of blood dendritic cells.Decreased HIV-specific T-regulatory responses are associated with effective DC-vaccine induced immunityBlood gene expression profiles suggest altered immune function associated with symptoms of generalized anxiety disorderDelineation of a novel dendritic-like subset in human spleen.Cellular vaccines in listeriosis: role of the Listeria antigen GAPDH.Dendritic cell-based vaccines: clinical applications in breast cancer.Targeting human dendritic cells in situ to improve vaccines.Self-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: potential clinical impact.Minor histocompatibility Ags: identification strategies, clinical results and translational perspectives.Vaccine delivery by penetratin: mechanism of antigen presentation by dendritic cells.Innate and Adaptive Immune Responses in Chronic HCV Infection.Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets.Trial watch: Dendritic cell-based interventions for cancer therapy.The Efficacy of CIK-Based Immunotherapies for Advanced Solid Tumors.Distinct features of dendritic cell-based immunotherapy as cancer vaccines.The roles of CSFs on the functional polarization of tumor-associated macrophages.The Biology of Monocytes and Dendritic Cells: Contribution to HIV Pathogenesis.
P2860
Q27024047-CD080FF4-E333-4D18-A9F7-972D3B328C28Q27025891-A54FDA52-C8FD-410C-9373-1020D36C11D0Q28066069-80889922-CC15-4E72-827C-FB876B9B5A05Q28074437-24D9FC4C-CC12-4917-84D3-ECE5973B6E63Q33820300-AC593C13-C655-4306-9F7D-C69837470582Q34543668-E4FBAAF4-F415-4223-91EC-0C070B0F7C85Q35116485-64A5C4E2-8E59-46CB-B5A4-10EB47FF00ECQ35224581-273043C2-0E01-457E-B518-A80F1937AEA9Q35226572-B3A72A50-87A5-4BFE-9397-A4B324214F61Q37101113-5190DDF8-0224-4CC0-AD88-7C0690F1E4A5Q37595946-57C29613-668A-4C68-AA39-BF4EC6559E16Q38206821-AE8A9671-AA56-4AB3-9861-6F198B06D7B4Q38235001-43116F18-5E57-493D-A7BB-D32392654BC1Q38279548-B6C4640E-1AC4-442C-8033-7490B7DF8C2CQ38616461-B36D2E29-C4AE-436D-A654-42C0758668EAQ38872440-FF6B02C8-F0EA-4469-9D36-63EF2AAF025CQ41035955-B1A993DB-962A-47CA-A73E-818A56CD8138Q41835523-5E088746-5DD5-4A7B-937E-C6CB5ECF015AQ42867339-1A0223D9-154B-4F6D-A7EC-4098F371A2F7Q47093613-5BF4A386-71D4-4A94-ABA3-7B8B0516FC0DQ48109150-1AF589DE-742D-4E51-ACE6-649EDD27B830Q49684254-9B20E946-2F72-409C-9E00-40A667BD1FAFQ50131761-D529DA3E-44B4-4669-8240-A257F0CC5BDC
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Human dendritic cell subsets in vaccination.
@en
type
label
Human dendritic cell subsets in vaccination.
@en
prefLabel
Human dendritic cell subsets in vaccination.
@en
P2860
P1476
Human dendritic cell subsets in vaccination.
@en
P2093
Karolina Palucka
P2860
P304
P356
10.1016/J.COI.2013.05.001
P577
2013-05-30T00:00:00Z